RespireRx Pharmaceuticals Inc (PK) (RSPI) News

https://stockcharts.com/h-sc/ui?s=rspi&p=W&yr=1&mn=6&dy=0&id=p24986097784&listNum=23&a=1113701411

News: RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI) Short Interest Down 73.1% in April.

RespireRx Pharmaceuticals Short Interest Data
Change Vs. Previous Month: 73.07%
Short Interest Ratio / Days to Cover: 0.0
Last Record Date: April 15, 2024
Outstanding Shares: 774,680,000 shares
Percentage of Shares Shorted: 0.00%

https://mayfieldrecorder.com/2024/04/25/respirerx-pharmaceuticals-inc-otcmktsrspi-short-interest-down-73-1-in-april.html

https://www.marketbeat.com/stocks/OTCMKTS/RSPI/short-interest/

Today we might get out of the trips.

Nice pricing too, we wait patiently for the upswing in price.


$RSPI

tight

Gotcha

Maybe. Self-imposed quiet period possibly?

It is odd that they have ignored the 10-k and shareholders which is unlike their history. As discussed on the forum, there could be early indications as to how the tier 3 NIH preclincals are shaping up and if positive, it is only logical that BP would gobble up control of the drug candidate asap.

LOI, NOT LOU

Negotiations happen before LOU, and other formal stuff. Wonder if the silence is more people, companies planning, doing DD on a formal agreement of some kind. $100k sounds more like a bridge loan ...so maybe they are near a really stupendous announcement for how they will be going forward?

LOL, well if that is their intent, they are doing a really bad job at it!

No updates on OSA or any drug programs, no timelines/milestones, can't even get a 10-K out. Yet, somehow BOD memeber loans them 100K with only some warrants to back it up. Silence still speaks.

When is the next pump? More needs to cash out. - Jeff

.05++ coming soon imo this is undiscovered imo

https://stockcharts.com/h-sc/ui?s=rspi&p=W&yr=1&mn=6&dy=0&id=p24986097784&listNum=23&a=1113701411

https://www.marketreportsworld.com/TOC/26519731?trk=article-ssr-frontend-pulse_little-text-block

GLOBAL EXPLODING HEAD SYNDROME TREATMENT INDUSTRY TRENDS ANALYSIS REPORT 2024, FORECAST TO 2032 (BROKEN DOWN BY TYPE, END USER, REGIONAL ANALYSIS, AND COMPETITIVE LANDSCAPE)

From the table of contents:

“8 Leading Companies Profiles
8.1 Respirerx Pharmaceuticals
8.1.1 Respirerx Pharmaceuticals Corporation Information
8.1.2 Respirerx Pharmaceuticals - Exploding Head Syndrome Treatment Product Portfolio and Specification
8.1.3 Respirerx Pharmaceuticals Performance Analysis (2019-2024)
8.1.4 Respirerx Pharmaceuticals Business and Markets Served
8.1.5 Respirerx Pharmaceuticals Recent Developments
8.2 Jazz Pharmaceutical
8.2.1 Jazz Pharmaceutical Corporation Information
8.2.2 Jazz Pharmaceutical - Exploding Head Syndrome Treatment Product Portfolio and Specification
8.2.3 Jazz Pharmaceutical Performance Analysis (2019-2024)
8.2.4 Jazz Pharmaceutical Business and Markets Served
8.2.5 Jazz Pharmaceutical Recent Developments
8.3 Arena Pharmaceuticals
8.3.1 Arena Pharmaceuticals Corporation Information
8.3.2 Arena Pharmaceuticals - Exploding Head“

RSPI in with the big boys sharky

Nice info thanks: HOLY SMOKES DID YOU LOOK AT THE COMPANIES RESPIRE IS LISTED WITH!!!!!!!!!!!!!!!!!!!!!
• Arena Pharmaceuticals
• Boehringer Ingelheim
• Fabre-Kramer Pharmaceuticals
• Jazz Pharmaceutical
• Merck & Co
• Glaxo Smith Kline
• Respirerx Pharmaceuticals
• Neurocrine Biosciences


$RSPI

HOLY SMOKES DID YOU LOOK AT THE COMPANIES RESPIRE IS LISTED WITH!!!!!!!!!!!!!!!!!!!!!
• Arena Pharmaceuticals
• Boehringer Ingelheim
• Fabre-Kramer Pharmaceuticals
• Jazz Pharmaceutical
• Merck & Co
• Glaxo Smith Kline
• Respirerx Pharmaceuticals
• Neurocrine Biosciences

1) Arena Pharmaceuticals was bought by Pfizer
Pfizer Completes Acquisition of Arena Pharmaceuticals
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-arena-pharmaceuticals
2)Boehringer Ingelheim
As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim,
https://en.wikipedia.org/wiki/Boehringer_Ingelheim
3)Fabre-Kramer Pharmaceuticals, Inc.
Fabre-Kramer Pharmaceuticals, Inc. (“FKP” or the “Company”), was formed to identify, develop and commercialize psychotropic drugs with significant market potential.
https://fabrekramer.com/about-us/
4) Jazz Pharmaceutical
Jazz Pharmaceutical (JAZZ ) CURRENTLY TRADING AT $107.99
https://finance.yahoo.com/quote/JAZZ/
5) Merck & Co
Merck & Co (MRK) CURRENTLY TRADING AT $126.90
https://finance.yahoo.com/quote/MRK/
6) Glaxo Smith Kline
Glaxo Smith Kline (GSK) CURRENTLY TRADING AT $40.91
https://finance.yahoo.com/quote/GSK/
7) Neurocrine Biosciences
Neurocrine Biosciences CURRENTLY TRADING AT $139.08
https://finance.yahoo.com/quote/NBIX/

Some news, alternative indication for Respirerx RSPI pipeline, cited as key player.

A condition related to obstructive sleep apnea - exploding head syndrome (really!).

https://www.bigouden.tv/2024/04/23/traitement-du-syndrome-de-la-tete-qui-explose-analyse-du-marche-paysage-concurrentiel-facteurs-de-croissance-revenus-fabre-kramer-pharmaceuticals-jazz-pharmaceutical-merck-co/

“Les principaux acteurs sont également clairement ciblés dans le rapport, avec des faits et des chiffres mentionnés.

• Arena Pharmaceuticals
• Boehringer Ingelheim
• Fabre-Kramer Pharmaceuticals
• Jazz Pharmaceutical
• Merck & Co
• Glaxo Smith Kline
• Respirerx Pharmaceuticals
• Neurocrine Biosciences”

https://www.statsndata.org/report/exploding-head-syndrome-treatment-market-30870

“EXPLODING HEAD SYNDROME TREATMENT MARKET RESEARCH REPORT FOR 2023: EXPLORING FUTURE OPPORTUNITIES, EMERGING TRENDS, COMPREHENSIVE ANALYSIS, AND FORECAST UNTIL 2029

Key Players
Arena Pharmaceuticals
Boehringer Ingelheim
Fabre-Kramer Pharmaceuticals
Jazz Pharmaceutical
Merck & Co
Glaxo Smith Kline
Respirerx Pharmaceuticals
Neurocrine Biosciences”

I agree.

Even if you assume it takes the entire OS of 2 billion shares to satisfy all warrants and notes outstanding.... essentially fully diluted.. Probably wont be near that much...

.02 would be a 40 million mrkt cap
.08 would be a 160 million mrkt cap

Considering they have an OSA program supposedly "valued" around 20 million, that assuming they are completeing some preclinical work on the new formulations in preps to launch human trials in late stages. And their promising SCI/ADHD candidate is waiting funding to continue human trials in later stages as well.

And then the pain/epilepsy candidate progressing through NIH preclinicals, which if successful as they appear confident in, would open up grant funding for human trials. Which would then be a high profile candidate that could help mitigate opioids. I've seen other preclinical pharma deals in the 10's to hundreds of million upfront, with potential milestone payments dwarfing that. Feels just like accumulating at pennies on the dollar here. But for balance, there is still plenty of risk in pharma industry, huge thresholds have to be met to advance any drug candidate. And maybe that is just simply where this is at currently. Insiders and institutional according to filings appear to be lining up with equity positions that can possibly pay off massively if their drug candidates successfully advance. Success not guaranteed but if it happens, I think we all can imagine how quickly the stock will gain traction and become one of those OTC story stocks... IMO

I’m ready! This should be at least.02-.08+ right now! This is crazy at .0008 lol

I would take either ,

A buyout at $2.50-$5.00/share for the entire pipeline would be a sweet deal for a BP company looking to expand their horizons

IMO, a succesful drug candidate passing phase 3 human clinicals that can replace the awful impact of opioids for pain management is worth billions easily. Getting to that point takes funding and resources of a BP, so RSPI would give up majority of equity in that asset. Since their filings indicate many insiders are looking for a payment event to trigger equity compensatio, then I would expect a partnership with cash and milestone type payments. Whether BP wants to deal with OTC shenanagins, is another story. Maybe a buyout would be more desireable, but value increases exponentially with each passing of human clincals, phase 1,2,3...Maybe RSPI uplists to a higher exchange to pursue their other drug programs in the works.

All speculation of course but I think minimum dimes and quarters are possible with a BP deal. Makes the risk v. reward extremely attractive here.

I would tend to agree. Considering that NIH desires more expiditious results and assuming animal trials to test addicitive liability are well underway or in progress, I would think there should be some early indication as to whether there is anything to stall going directly into phase 1 human trials. BP would almost be necessary at this point or highly encouraged to pursue.

If they continue to get good results for the other potential drugs. Then I would lean towards a buyout. If it remains just one drug. Then a partnership is more likely. Either way. the share price jumps and we benefit as well as the rest of the world. Just the pain med alone would be a enormous to say the least. No guess but $5 a share is not unrealistic. The share structure of the company is pretty good without billions upon billions of outstanding shares.

What is your take a , partnership or buyout. If a buyout what are you thinking 5-10B with knowing what they would make over time

I'm only guessing and speculating here but... I think that BP would be using inside information on how the 3rd stage tests are going and if it looks like they will come out of tat stage with more good news. Then BP would probably pounce on it. BP would probably assume that NIH is involved and the drug market is looking for an answer to the addiction issue that plagues the world. They would want in knowing that the process should move quickly.

Is BP waiting for the pain drug to make it through the 3rd preclinical and the 1st clinical with people b4 having the scientific data it needs...knowing nothing about the chemistry, am wondering at what point any BP would consider continued positive progress the "point at which to pounce"?

Yes. I think BP is watching this with great interest. This has moved along quickly and they wont fall a sleep at the wheel and miss what's next for this company without having a hand in it. I feel it will drop without warning and be one of those OTC companies that runs off the chart before most people can even get near it.

Anyone thinking we will get news by August or sooner

Ladies and gentlemen..
We have a winner..
This is truly a POS!!!!!
DOWN DOWN DOWN!!
RSPI WAHT A POS!!!!

Ladies and gentlemen..
We have a winner..
This is truly a POS!!!!!
DOWN DOWN DOWN!!
RSPI WAHT A POS!!!!

I think for the few folks following this forum, likely the truck has been backed up, accumulated and set aside to allow the drug development efforts for OSA and especially the high profile KRM-II-81 to percolate and mature.

Even those doing cursory DD on pharma industry can understand the implications and value if the NIH greenlights KRM-II-81 currently in tier 3 preclinicals. The potential to mitigate the opioid crisis is astounding, and worth my speculative monies. Considering how undervalued this stock is, one could wake up one day and it open 10x higher and upward from there. That is how ridiculous I perceive this, but that is my opinion and to each their own.

As I continue to say...
For all you bulls....
Why are you not lifting the offer or bidding this stock higher???
There are only 712200 shares on the ask..lift that offer!!
Put your money where your mouth is...
Otherwise, stop pretending to be soooo bullish....
At these prices, you should be buy hand over fist...
Back the truck up and load up!!!
Unbelievable!!!

As I continue to say...
For all you bulls....
Why are you not lifting the offer or bidding this stock higher???
There are only 712200 shares on the ask..lift that offer!!
Put your money where your mouth is...
Otherwise, stop pretending to be soooo bullish....
At these prices, you should be buy hand over fist...
Back the truck up and load up!!!
Unbelievable!!!

Crow crows…

I think you may be off a decimal, but needless to say, there has been chunk buys over the past 4 months and lately hardly any dollar volume to speak of. IMO, just a holding pattern until more info is known via 10-k, or some status update on OSA program or the pain/epilepsy tier 3 trials with NIH. I think it is a good sign that BOD memeber loans 100k with only the .0015 warrants to back it up. One would think if there was nothing of significance/value on the horizon, this would be unlikely. Easy accumulate and hold here.

It is interesting looking at other preclinical/IND/phase 1 big pharma deals. Some are anywhere from 10's of million to hundreds of million up front cash with milestone payments possibly well into the hundreds of millions. As the CEO stated if they pass tier 3 preclinicals, they will be open for grant money, but more than likely I would think be striking a similar deal of significance for BP to take the ball and run with it. Such would allow them to focus energy and funds then to one of the other drug platforms they have in the works.

Probably be a fairly boring stock until then I suppose, although as someone mentioned, that seems to be the best case scenario for stocks of this nature. Do nothing, and then strike massive deal, trade for nickels and dimes and more... GLTA.

12:08 est.

6 , purchases of over 100k, less than a million, so in the thousands of dollars...

2 purchases of over a million shares so over ten-thousands of dollars.

Bullish!

Still looking for 10-K filing that is late. However, did see they had an 8-K filing where a BOD member provided a loan, with warrants at .0015. Another example of insiders lining up with equity positions here.

Staying long, she will move eventually. Looking forward to phase 3 news ahead.


$RSPI

Thanks thought it was quite witty...lol.Nice buying today.

We’re getting there sharky. Cmon PENNYLAND

Any thoughts on when we could see any phase 3 news

Ace LoL i love it
RSPI 🟢💚🚀

Nice to see RSPI close up today

$RSPI pipeline: https://respirerx.com/product-pipeline/

For your sake, I hope you are right. Do you truly believe that these guys are not going to keep diluting and then do another RS.

You eating crow.

closer to what?

RSPI getting closer and closer.